Búsqueda - Portal Conocimiento Público CL

Other publications 2020-04-13

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Autor: Gordon, Calvin J. et al.

Enlace original: https://covid19-evidence.paho.org/handle/20.500.12663/1185

covid-19 evidence paho

COVID-19

Coronavirus

Infectious Diseases

Citar Enlace permanente

Gordon, Calvin J. et al. , [Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency]

Descubre y comparte nuestro conocimiento público

Resultados de búsqueda

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Pivotal Role of Convalescent Plasma in Managing Emerging Infectious Diseases